E-resources
Peer reviewed
-
Jodai, Takayuki; Saruwatari, Koichi; Ikeda, Tokunori; Moriyama, Eiji; Kashiwabara, Kosuke; Shingu, Naoki; Iyonaga, Kazuhiro; Inaba, Megumi; Ajishi, Yusuke; Honda, Chiharu; Hirosako, Susumu; Maruyama, Hirotaka; Kakiuchi, Yosuke; Eida, Hirofumi; Tomita, Yusuke; Saeki, Sho; Ichiyasu, Hidenori; Sakagami, Takuro
International journal of clinical oncology, 2021/1, Volume: 26, Issue: 1Journal Article
Background Anti-programmed cell death protein-1/ligand-1 (anti-PD-1/PD-L1) therapy is promising for patients with non-small-cell lung cancer (NSCLC); however, clinical trials have focused on patients with a performance status (PS) 0 or 1. This study aimed to evaluate the clinical outcomes and correlation between PD-L1 expression status and tumor response to anti-PD-1/PD-L1 therapy among NSCLC patients with poor PS (i.e., PS ≥ 2). Methods In total, 130 patients with NSCLC and PS ≥ 2 treated with anti-PD-1/PD-L1 monotherapy at 12 institutions between January 2016 and August 2019 were retrospectively reviewed. PD-L1 expression status was divided into four groups: < 1%, 1–49%, ≥ 50%, and unknown. Results The objective response rate and PS improvement rate were 23 and 21% and were higher in the PD-L1 ≥ 50% group than in other groups ( P < 0.01). Median progression-free survival (PFS) was 62 days and was longer in the PD-L1 ≥ 50% group than in other groups ( P = 0.03). Multivariate analyses revealed that PD-L1 expression is significantly associated with prolonged PFS (PD-L1 < 1%; reference; 1–49%, hazard ratio HR 0.19, 95% confidence interval CI 0.04–0.99, P = 0.05; ≥ 50%, HR 0.12, 95% CI 0.02–0.71, P = 0.02; unknown, HR 0.30, 95% CI 0.08–1.22, P = 0.09). Conclusions NSCLC patients with poor PS and PD-L1 ≥ 50% are expected to benefit from anti-PD-1/PD-L1 therapy, despite a modest overall response among NSCLC patients with poor PS. Accordingly, PD-L1 expression provides useful information regarding decision-making for anti-PD-1/PD-L1 therapy even in these populations.
Author
Shelf entry
Permalink
- URL:
Impact factor
Access to the JCR database is permitted only to users from Slovenia. Your current IP address is not on the list of IP addresses with access permission, and authentication with the relevant AAI accout is required.
Year | Impact factor | Edition | Category | Classification | ||||
---|---|---|---|---|---|---|---|---|
JCR | SNIP | JCR | SNIP | JCR | SNIP | JCR | SNIP |
Select the library membership card:
If the library membership card is not in the list,
add a new one.
DRS, in which the journal is indexed
Database name | Field | Year |
---|
Links to authors' personal bibliographies | Links to information on researchers in the SICRIS system |
---|
Source: Personal bibliographies
and: SICRIS
The material is available in full text. If you wish to order the material anyway, click the Continue button.